Baseline Striatal Functional Connectivity as a Predictor of Response to Antipsychotic Drug Treatment

The American Journal of Psychiatry
Deepak K SarpalAnil K Malhotra

Abstract

Clinical response to antipsychotic drug treatment is highly variable, yet prognostic biomarkers are lacking. The authors recently demonstrated that successful antipsychotic drug treatment alters resting-state functional connectivity of the striatum. The goal of the present study was to test whether intrinsic striatal connectivity patterns provide prognostic information and can serve as a potential biomarker of treatment response to antipsychotic drugs. The authors used resting-state functional MRI (fMRI) to develop a prognostic index in a discovery cohort of 41 first-episode schizophrenia patients, then tested this index in an independent cohort of 40 newly hospitalized chronic patients with acute psychosis. In the discovery cohort, patients underwent resting-state fMRI scanning at the initiation of randomized controlled treatment with a second-generation antipsychotic. Whole-brain functional connectivity maps were generated for each subject from striatal seed regions. A stringent measure of clinical response was calculated that required sustained improvement over two consecutive study visits. Clinical response was entered into a survival analysis, and Cox regression was applied to the functional connectivity data. A striatal c...Continue Reading

Associated Clinical Trials

Dec 17, 2020·Juan Gallego Angel

Citations

Jul 12, 2016·Schizophrenia Research·E J BrandlD J Müller
Oct 28, 2016·Frontiers in Psychiatry·André Schmidt, Stefan Borgwardt
Feb 24, 2017·Nature Neuroscience·Choong-Wan WooTor D Wager
Mar 16, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak K SarpalAnil K Malhotra
Nov 13, 2017·European Archives of Psychiatry and Clinical Neuroscience·Mingli LiTao Li
Aug 25, 2018·Brain Connectivity·Michelle E Fox, Tricia Z King
Apr 17, 2019·Proceedings of the National Academy of Sciences of the United States of America·Justin T BakerAvram J Holmes
Nov 26, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Yuya MizunoOliver D Howes
Feb 7, 2020·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Qi MiaoXin Yu
Apr 22, 2018·Molecular Psychiatry·Sameer JauharOliver D Howes
Jan 27, 2019·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Philipp HomanAnil K Malhotra
Jun 22, 2018·Frontiers in Psychiatry·Lee Jollans, Robert Whelan
Aug 18, 2020·Schizophrenia Bulletin Open·Melanie Blair ThiesAnil K Malhotra
Jun 2, 2018·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Christoph U CorrellJohn M Kane
Sep 23, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mattia VeroneseOliver Howes
Apr 22, 2020·NPJ Schizophrenia·Carina Seah, Kristen J Brennand
Apr 24, 2019·Brain Sciences·Camilla L NordJonathan P Roiser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here